Detection of human cytomegalovirus IgG antibody using automated immunoassay with recombinant antigens gives uniform results to established assays using whole virus antigens

Fatma Baalawi, Peter Robertson, William D. Rawlinson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim: Serological testing for human cytomegalovirus (CMV) immunoglobulin G (IgG) continues to play a major role in the evaluation of tissue and organ transplant donors and recipients, screening blood donors and in estimating the risk of infection in pregnant women. In this study we evaluated the performance and technical characteristics of two semi-automated commercial CMV IgG immunoassays. Methods: One hundred consecutive sera submitted to a referral serology laboratory for CMV IgG antibody testing were assayed using two automated CMV IgG immunoassays: the Architect (Abbott Diagnostics) and Elecsys (Roche Diagnostics) immunoassays. Because this patient population has a high rate (∼87) of seropostivity, we took a further 50 sera that were CMV IgG negative on Architect and tested on the Elecsys assay, in order to assess the specificity of the assays. Results: The assays showed an excellent qualitative agreement with two (2) discrepant results in the 100 patients tested initially, with all of the 50 additional sera negative on Architect also negative on the Elecsys. However, there was no correlation between the optical density of results generated by the instruments for the set of samples. Conclusion: Both Elecsys and Architect immunoassays are convenient for detection of CMV IgG antibody, with near identical qualitative results.

Original languageEnglish
Pages (from-to)578-580
Number of pages3
JournalPathology
Volume42
Issue number6
DOIs
Publication statusPublished - 2010

Fingerprint

Cytomegalovirus
Immunoassay
Immunoglobulin G
Viruses
Antigens
Antibodies
Serum
Tissue Donors
Transplants
Donor Selection
Serology
Blood Donors
Pregnant Women
Referral and Consultation
Infection
Population

Keywords

  • CMV
  • CMV IgG
  • Cytomegalovirus
  • Immunoglobulin G

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Detection of human cytomegalovirus IgG antibody using automated immunoassay with recombinant antigens gives uniform results to established assays using whole virus antigens. / Baalawi, Fatma; Robertson, Peter; Rawlinson, William D.

In: Pathology, Vol. 42, No. 6, 2010, p. 578-580.

Research output: Contribution to journalArticle

@article{808da25c31b9451882e2f4c9b21aa446,
title = "Detection of human cytomegalovirus IgG antibody using automated immunoassay with recombinant antigens gives uniform results to established assays using whole virus antigens",
abstract = "Aim: Serological testing for human cytomegalovirus (CMV) immunoglobulin G (IgG) continues to play a major role in the evaluation of tissue and organ transplant donors and recipients, screening blood donors and in estimating the risk of infection in pregnant women. In this study we evaluated the performance and technical characteristics of two semi-automated commercial CMV IgG immunoassays. Methods: One hundred consecutive sera submitted to a referral serology laboratory for CMV IgG antibody testing were assayed using two automated CMV IgG immunoassays: the Architect (Abbott Diagnostics) and Elecsys (Roche Diagnostics) immunoassays. Because this patient population has a high rate (∼87) of seropostivity, we took a further 50 sera that were CMV IgG negative on Architect and tested on the Elecsys assay, in order to assess the specificity of the assays. Results: The assays showed an excellent qualitative agreement with two (2) discrepant results in the 100 patients tested initially, with all of the 50 additional sera negative on Architect also negative on the Elecsys. However, there was no correlation between the optical density of results generated by the instruments for the set of samples. Conclusion: Both Elecsys and Architect immunoassays are convenient for detection of CMV IgG antibody, with near identical qualitative results.",
keywords = "CMV, CMV IgG, Cytomegalovirus, Immunoglobulin G",
author = "Fatma Baalawi and Peter Robertson and Rawlinson, {William D.}",
year = "2010",
doi = "10.3109/00313025.2010.508778",
language = "English",
volume = "42",
pages = "578--580",
journal = "Pathology",
issn = "0031-3025",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Detection of human cytomegalovirus IgG antibody using automated immunoassay with recombinant antigens gives uniform results to established assays using whole virus antigens

AU - Baalawi, Fatma

AU - Robertson, Peter

AU - Rawlinson, William D.

PY - 2010

Y1 - 2010

N2 - Aim: Serological testing for human cytomegalovirus (CMV) immunoglobulin G (IgG) continues to play a major role in the evaluation of tissue and organ transplant donors and recipients, screening blood donors and in estimating the risk of infection in pregnant women. In this study we evaluated the performance and technical characteristics of two semi-automated commercial CMV IgG immunoassays. Methods: One hundred consecutive sera submitted to a referral serology laboratory for CMV IgG antibody testing were assayed using two automated CMV IgG immunoassays: the Architect (Abbott Diagnostics) and Elecsys (Roche Diagnostics) immunoassays. Because this patient population has a high rate (∼87) of seropostivity, we took a further 50 sera that were CMV IgG negative on Architect and tested on the Elecsys assay, in order to assess the specificity of the assays. Results: The assays showed an excellent qualitative agreement with two (2) discrepant results in the 100 patients tested initially, with all of the 50 additional sera negative on Architect also negative on the Elecsys. However, there was no correlation between the optical density of results generated by the instruments for the set of samples. Conclusion: Both Elecsys and Architect immunoassays are convenient for detection of CMV IgG antibody, with near identical qualitative results.

AB - Aim: Serological testing for human cytomegalovirus (CMV) immunoglobulin G (IgG) continues to play a major role in the evaluation of tissue and organ transplant donors and recipients, screening blood donors and in estimating the risk of infection in pregnant women. In this study we evaluated the performance and technical characteristics of two semi-automated commercial CMV IgG immunoassays. Methods: One hundred consecutive sera submitted to a referral serology laboratory for CMV IgG antibody testing were assayed using two automated CMV IgG immunoassays: the Architect (Abbott Diagnostics) and Elecsys (Roche Diagnostics) immunoassays. Because this patient population has a high rate (∼87) of seropostivity, we took a further 50 sera that were CMV IgG negative on Architect and tested on the Elecsys assay, in order to assess the specificity of the assays. Results: The assays showed an excellent qualitative agreement with two (2) discrepant results in the 100 patients tested initially, with all of the 50 additional sera negative on Architect also negative on the Elecsys. However, there was no correlation between the optical density of results generated by the instruments for the set of samples. Conclusion: Both Elecsys and Architect immunoassays are convenient for detection of CMV IgG antibody, with near identical qualitative results.

KW - CMV

KW - CMV IgG

KW - Cytomegalovirus

KW - Immunoglobulin G

UR - http://www.scopus.com/inward/record.url?scp=77956932236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956932236&partnerID=8YFLogxK

U2 - 10.3109/00313025.2010.508778

DO - 10.3109/00313025.2010.508778

M3 - Article

VL - 42

SP - 578

EP - 580

JO - Pathology

JF - Pathology

SN - 0031-3025

IS - 6

ER -